Alcon (ALC) Common Equity (2009 - 2026)
Alcon (ALC) posted quarterly Common Equity of $22.1 billion for Q1 2026, up 2878.87% year-on-year from $743.0 million in Q1 2025, and little changed on a QoQ basis from $22.0 billion in Q4 2025.
Alcon (ALC) Common Equity (2009 - 2026) Analysis & Trends
Alcon (ALC) has reported Common Equity for 11 consecutive years, with $22.1 billion the latest figure, recorded in Q1 2026.
- Quarterly Common Equity rose 2878.87% year-over-year to $22.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.1 billion (up 2878.87% YoY) and the FY2025 annual result came in at $22.0 billion, up 2.24% from the prior year.
- Common Equity was little changed at $22.1 billion in Q1 2026 per ALC's latest filing, from $22.0 billion in the prior quarter.
- Over the last five years, Common Equity for ALC reached as high as $22.1 billion in Q1 2026 and fell as low as $743.0 million in Q1 2025.
- A 5-year average of $19.6 billion and a median of $20.6 billion in 2023 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2025 — Common Equity slumped 96.43% — and 2026, when it jumped 2878.87%.
- Year by year, Common Equity stood at $19.7 billion in 2022, then grew by 4.81% to $20.6 billion in 2023, then increased by 4.5% to $21.6 billion in 2024, then gained by 2.24% to $22.0 billion in 2025, then advanced by 0.44% to $22.1 billion in 2026.
- According to Business Quant data, Common Equity over the past three periods registered $22.1 billion, $22.0 billion, and $22.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 22.13 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 18.30 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 24.13 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 11.27 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 6.49 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 2.99 Bn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 8.24 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 4.97 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 4.15 Bn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | 6.04 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.13 Bn |
| Dec 31, 2025 | 22.04 Bn |
| Sep 30, 2025 | 22.09 Bn |
| Jun 30, 2025 | 22.13 Bn |
| Mar 24, 2025 | 743.00 Mn |
| Dec 31, 2024 | 21.55 Bn |
| Sep 30, 2024 | 21.39 Bn |
| Jun 30, 2024 | 20.94 Bn |
| Mar 31, 2024 | 20.83 Bn |
| Dec 31, 2023 | 20.62 Bn |
| Sep 30, 2023 | 20.15 Bn |
| Jun 30, 2023 | 19.94 Bn |
| Mar 31, 2023 | 19.86 Bn |
| Dec 31, 2022 | 19.68 Bn |
| Sep 30, 2022 | 19.65 Bn |
| Jun 30, 2022 | 19.54 Bn |
| Mar 31, 2022 | 19.49 Bn |
| Dec 31, 2021 | 19.26 Bn |
| Sep 30, 2021 | 19.09 Bn |
| Jun 30, 2021 | 19.06 Bn |